Omega Healthcare Investors, Inc. (NYSE:OHI) has earned a consensus recommendation of “Hold” from the ten brokerages that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and two have assigned a buy rating to the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $30.49.

Several equities research analysts have recently weighed in on the stock. Capital One Financial assumed coverage on shares of Omega Healthcare Investors in a research report on Monday, October 23rd. They set an “equal weight” rating and a $34.00 price objective for the company. Vetr cut shares of Omega Healthcare Investors from a “buy” rating to a “hold” rating and set a $33.33 price objective for the company. in a research report on Thursday, October 19th. ValuEngine cut shares of Omega Healthcare Investors from a “buy” rating to a “hold” rating in a research report on Wednesday, September 6th. Zacks Investment Research upgraded shares of Omega Healthcare Investors from a “sell” rating to a “buy” rating and set a $35.00 price objective for the company in a research report on Wednesday, October 4th. Finally, Jefferies Group reiterated a “hold” rating and set a $30.00 price objective on shares of Omega Healthcare Investors in a research report on Tuesday, October 3rd.

Omega Healthcare Investors (OHI) traded up $0.52 on Monday, hitting $27.59. 2,530,300 shares of the stock traded hands, compared to its average volume of 2,177,199. Omega Healthcare Investors has a 52 week low of $26.43 and a 52 week high of $35.14. The company has a debt-to-equity ratio of 1.18, a quick ratio of 3.40 and a current ratio of 3.40. The firm has a market capitalization of $5,464.84, a PE ratio of 8.11, a PEG ratio of 2.87 and a beta of 0.49.

The business also recently declared a quarterly dividend, which was paid on Wednesday, November 15th. Shareholders of record on Tuesday, October 31st were issued a $0.65 dividend. This represents a $2.60 dividend on an annualized basis and a yield of 9.42%. This is a boost from Omega Healthcare Investors’s previous quarterly dividend of $0.64. The ex-dividend date of this dividend was Monday, October 30th. Omega Healthcare Investors’s dividend payout ratio (DPR) is presently 317.08%.

In related news, Director Bernard J. Korman purchased 100,000 shares of Omega Healthcare Investors stock in a transaction on Tuesday, October 31st. The stock was acquired at an average cost of $28.24 per share, for a total transaction of $2,824,000.00. Following the completion of the acquisition, the director now owns 903,895 shares of the company’s stock, valued at approximately $25,525,994.80. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Craig R. Callen purchased 10,000 shares of Omega Healthcare Investors stock in a transaction on Thursday, November 2nd. The stock was bought at an average price of $27.38 per share, with a total value of $273,800.00. The disclosure for this purchase can be found here. Company insiders own 1.54% of the company’s stock.

Large investors have recently bought and sold shares of the business. Bronfman E.L. Rothschild L.P. grew its holdings in shares of Omega Healthcare Investors by 167.7% during the second quarter. Bronfman E.L. Rothschild L.P. now owns 3,432 shares of the real estate investment trust’s stock valued at $113,000 after buying an additional 2,150 shares during the last quarter. Ffcm LLC grew its holdings in shares of Omega Healthcare Investors by 197.6% during the second quarter. Ffcm LLC now owns 3,402 shares of the real estate investment trust’s stock valued at $115,000 after buying an additional 2,259 shares during the last quarter. Barnett & Company Inc. grew its holdings in shares of Omega Healthcare Investors by 1,980.0% during the third quarter. Barnett & Company Inc. now owns 5,200 shares of the real estate investment trust’s stock valued at $166,000 after buying an additional 4,950 shares during the last quarter. Mcmillion Capital Management Inc. acquired a new position in shares of Omega Healthcare Investors during the third quarter valued at about $201,000. Finally, Timber Hill LLC acquired a new position in shares of Omega Healthcare Investors during the third quarter valued at about $206,000. Institutional investors and hedge funds own 68.14% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Omega Healthcare Investors, Inc. (OHI) Given Average Rating of “Hold” by Analysts” was originally reported by American Banking News and is the property of of American Banking News. If you are accessing this news story on another website, it was illegally copied and republished in violation of US & international copyright & trademark law. The legal version of this news story can be read at https://www.americanbankingnews.com/2017/12/11/omega-healthcare-investors-inc-ohi-given-average-rating-of-hold-by-analysts.html.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.

Analyst Recommendations for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.